|
|
|
Jacob Fleming Conferences, Hotel Marriott, Brussels
14th & 15th June 2006
Personalized medicine encompasses much more than genetics. New technologies and achievements in science have brought us a whole new way of thinking in medicine. In this forum, you can learn from the most experienced companies how to explore this field of huge medical and commercial potential. Get the most useful information in valuable presentations, interactive panel discussions, and networking coffee breaks & cocktail reception.Key topics: Which pharmaceutical areas can benefit most from personalized medicine? Moving from Pharmacogenetic Effect to Personalized Medicine What is the role of molecular diagnostic/predictive markers in this field? The commercial value of PGx - from internal decision making to improved market options
|
|
|
|
|
|
Organized by:
|
|
Jacob Fleming Group |
|
Invited Speakers:
|
|
Giuseppe Colucci, Roche Molecular Systems-RIC Medical Manager Scientific Affairs Duncan McHale, Pfizer Global R & D Senior Director and Head Molecular Profiling Steffen Stürzebecher, Schering AG Head of Global Pharmacogenomics, Global Preclinical Development Wayne Rosenkrans, Personalized Medicine Coalition, Vice Chair AstraZeneca, Business Strategy Director, External Scientific Affairs, AstraZeneca and many others...
|
|
|
|
|
|
Deadline for Abstracts:
|
|
see dates
|
|
|
|
|
|
Registration:
|
|
multiple bookings discount
|
|
E-mail:
|
|
events@jacobfleming.com
|
|
|
|
|
|
|
|